Interventional × Has results × Immunoglobulin Light-chain Amyloidosis × Clear all S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Phase 2 Completed
43 enrolled 23 charts
A Study to Evaluate the Safety and Tolerability of CAEL-101 in Patients With AL Amyloidosis
Phase 2 Completed
25 enrolled 14 charts
Bortezomib, Melphalan, and Dexamethasone in Treating Patients With Primary Amyloidosis or Light Chain Deposition Disease
Phase 2 Completed
35 enrolled 7 charts
COVID-19 VAX Booster Dosing in Patients With Hematologic Malignancies
Phase 2 Completed
119 enrolled 11 charts
VITAL
Phase 3 Terminated
260 enrolled 11 charts
Propylene Glycol-Free Melphalan Hydrochloride (Evomela) in AL Amyloidosis Patients
Phase 2 Terminated
27 enrolled 13 charts
Autologous Stem Cell Transplant Followed By Maintenance Therapy in Treating Elderly Patients With Multiple Myeloma
Phase 2 Completed
41 enrolled 12 charts
Melphalan and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Systemic Light-Chain Amyloidosis
Phase 3 Completed
11 enrolled 6 charts
DUAL
Phase 2 Completed
32 enrolled 15 charts
Daratumumab for the Treatment of Patients With AL Amyloidosis
Phase 1/2 Completed
22 enrolled 10 charts
CATALYST
Phase 1/2 Completed
10 enrolled 14 charts
Bortezomib and Dexamethasone Followed by High-Dose Melphalan and Stem Cell Transplantation for Primary (AL) Amyloidosis
Phase 2 Completed
35 enrolled 9 charts
Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer
Phase NA Terminated
1 enrolled 3 charts
A Phase I/II Trial of Pomalidomide and Dexamethasone in Subjects With Previously-Treated AL Amyloidosis
Phase 1/2 Completed
27 enrolled 14 charts
Bortezomib/Dexamethasone (BD), Followed By Autologous Stem Cell Transplantation and Maintenance Bortezomib/Dexamethasone For the Initial Treatment of Monoclonal Immunoglobulin Deposition Disease (MIDD) Associated With Multiple Myeloma and AL Amyloidosis
Phase NA Completed
20 enrolled 16 charts
Trial of Two Stem Cell Doses To Reduce Transplant Induced Symptom Burden
Phase 2 Completed
80 enrolled 7 charts
A Safety Study of GSK3039294 in Healthy Volunteers and Patients With Systemic Amyloidosis
Phase 1 Terminated
23 enrolled 25 charts
OLE
Phase 2 Terminated
34 enrolled 10 charts
PRONTO
Phase 2 Completed
129 enrolled 18 charts
Study in Subjects With Light Chain (AL) Amyloidosis
Phase 2 Terminated
80 enrolled 9 charts
VelRand
Phase 3 Terminated
3 enrolled 11 charts
S0115, High-Dose Melphalan and Autologous Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Primary Systemic Amyloidosis
Phase 2 Completed
104 enrolled 6 charts
Bu Flu TBI
Phase 1/2 Completed
147 enrolled 19 charts
Safety and Effect of Doxycycline in Patients With Amyloidosis
Phase 2 Completed
25 enrolled 13 charts
Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer
Phase NA Completed
5 enrolled 6 charts
HD Melphalan and SCT in Patients With IGDD or LCDD
Phase 2 Terminated
5 enrolled 7 charts
CC-5013 With or Without Dexamethasone in Treating Patients With Primary Systemic Amyloidosis
Phase 2 Completed
82 enrolled 9 charts
MRD
Phase 2 Completed
16 enrolled 9 charts
Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy
Phase 2 Completed
239 enrolled 23 charts
American Ginseng in Treating Patients With Fatigue Caused by Cancer
Phase 3 Completed
364 enrolled 29 charts
Melphalan, Bortezomib, and Stem Cell Transplant in Treating Patients With Primary Systemic Amyloidosis
Phase 2 Completed
10 enrolled 9 charts
2nd Autologous Stem Cell Transplant in Patients With Persistent/Recurrent (AL) Amyloidosis
Phase 2 Terminated
12 enrolled 6 charts
Melphalan and Autologous Stem Cell Transplant Followed By Bortezomib and Dexamethasone in Treating Patients With Previously Untreated Systemic Amyloidosis
Phase 2 Completed
40 enrolled 5 charts
Low-Dose Melphalan and Dexamethasone Compared With High-Dose Melphalan Followed By Autologous Stem Cell Transplant in Treating Patients With Primary Systemic Amyloidosis
Phase 3 Completed
89 enrolled 11 charts
Bortezomib, Cyclophosphamide, and Dexamethasone in Treating Patients With Primary Systemic Light Chain Amyloidosis
Phase 2 Completed
2 enrolled 9 charts
Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain
Phase 3 Completed
130 enrolled 9 charts
Human Immune Globulin in Treating Patients With Primary Amyloidosis That is Causing Heart Dysfunction
Phase 1/2 Completed
10 enrolled 4 charts
Lenalidomide, Cyclophosphamide, and Dexamethasone in Treating Patients With Primary Systemic Amyloidosis
Phase 2 Completed
35 enrolled 11 charts
Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain
Phase 3 Completed
98 enrolled 14 charts
Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer
Phase 3 Completed
502 enrolled 30 charts